VC-backed scPharmaceuticals rakes in almost $90 mln for IPO

By Iris Dorbian — 5 days ago

Burlington, Massachusetts-based scPharmaceuticals Inc, a biopharmaceutical company that is developing drugs for subcutaneous delivery, has raised $89.6 million for its IPO after pricing its 6.4 million shares at $14 per share. The stock began trading November 17, 2017 on the NASDAQ under the ticker symbol “SCPH.” Jefferies, Leerink Partners and BMO Capital Markets are the lead underwriters. The company’s pre-IPO backers include OrbiMed, 5AM Ventures and Lundbeckfond Ventures.

Continue

Bluegreen Vacations rolls out IPO

By Iris Dorbian — 5 days ago

Boca Raton, Florida-based Bluegreen Vacations, a vacation ownership company, has debuted its IPO after pricing its over 6.4 million shares at $14 per share. The stock began trading November 17, 2017 on the New York Stock Exchange under the ticker symbol “BXG.” Stifel and Credit Suisse are the lead underwriters. Bluegreen Vacations is backed by BBX Capital.

Continue

Thoma Bravo-backed SailPoint goes public

By Iris Dorbian — 5 days ago

SailPoint Technologies Holdings, a portfolio company of Thoma Bravo, has raised $240 million for its IPO after pricing its 20 million shares at $12 per share. The stock began trading November 17, 2017 on the New York Stock Exchange under the ticker symbol “SAIL.” Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Jefferies LLC and RBC Capital Markets LLC are the lead underwriters. Based in Austin, Texas, SailPoint is a provider of on-premises and SaaS-based identity and access management solutions.

Continue

VC-backed Arsanis goes public

By Iris Dorbian — 6 days ago

Waltham, Massachusetts-based Arsanis Inc, a developer of targeted monoclonal antibodies for treating serious infectious diseases, has raised $40 million for its IPO after pricing its IPO of four million shares at $10 per share. The stock began trading November 16, 2017 on the NASDAQ under the ticker symbol “ASNS.” Citigroup, Cowen and Company and Piper Jaffray & Co are the lead underwriters. And, in a separate transaction, New Enterprise Associates has agreed to provide $20 million to Arsanis in a private placement. Arsanis’ pre-IPO backers include the Bill & Melinda Gates Foundation, GV, Alexandria Venture Investments, OrbiMed, Polaris Venture Partners, SV Health Investors, NeoMed, EMBL Ventures and the Anna Maria and Stephen Kellen Foundation.

Continue

VC-backed Bandwidth goes public

By Iris Dorbian — 2 weeks ago

Raleigh, North Carolina-based Bandwidth, a telecom company, has raised $80 million for its IPO after pricing its 4 million shares at $20 per share. The stock began trading November 10, 2017 on the NASDAQ under the ticker symbol “BAND.” Morgan Stanley, KeyBanc Capital Markets and Baird are the lead underwriters. Bandwidth is backed by Carmichael Partners.

Continue

German biopharma company InflaRx goes public

By Iris Dorbian — 2 weeks ago

Germany-based InflaRx, a developer of new therapeutics in the “terminal complement space,” has raised about $100 million for its IPO after pricing its over 6.6 million shares at $15 per share. The stock began trading November 8, 2017 on the NASDAQ under the ticker symbol “IFRX.” J.P. Morgan, Leerink Partners and BMO Capital Markets are the lead underwriters. InflaRx’s backers include Bain Capital Life Sciences LP, Cormorant Asset Management LLC and RA Capital Management LLC.

Continue

Erytech Pharma sets IPO pricing terms

By Iris Dorbian — 2 weeks ago

Erytech Pharma, a French biopharmaceutical company, has priced its IPO of up to 4.26 million shares at between $23 and $24 per share. Erytech plans on listing the stock on the NASDAQ under the ticker symbol “ERYP.” Jefferies and Cowen & Company are among the underwriters. Erytech’s backers include Auriga Partners.

Continue

Apollo-backed Momentive sets IPO pricing terms

By Iris Dorbian — 2 weeks ago

Momentive, a maker of specialty silicones, has priced its IPO of over 14.5 million shares at between $23 and $25 per share. The stock will trade on the New York Stock Exchange under the ticker symbol “MPMH.” J.P. Morgan Securities LLC and Goldman Sachs are the lead underwriters. Momentive is backed by Apollo Global Management.

Continue

VC-backed ACM Research goes public

By Iris Dorbian — 3 weeks ago

Fremont, California-based ACM Research, a provider of advanced wafer cleaning technologies, has debuted its IPO after pricing its two million shares at $5.60 per share. The stock began trading November 3, 2017 on the NASDAQ under the ticker symbol “ACMR” Roth Capital Partners is the lead underwriter. ACM Research’s pre-IPO backers included Shanghai Science and Technology Venture Capital.

Continue